Mostrar el registro sencillo del ítem

dc.contributor.author
Talevi, Alan  
dc.contributor.author
Bruno Blanch, Luis Enrique  
dc.contributor.other
Talevi, Alan  
dc.contributor.other
Rocha Arrieta, Luisa Lilia  
dc.date.available
2020-06-12T15:58:30Z  
dc.date.issued
2016  
dc.identifier.citation
Talevi, Alan; Bruno Blanch, Luis Enrique; Virtual Screening Applications in the Search of Novel Antiepileptic Drug Candidates; Springer; 2016; 237-258  
dc.identifier.isbn
978-1-4939-6355-3  
dc.identifier.uri
http://hdl.handle.net/11336/107415  
dc.description.abstract
Virtual screening (VS) encompasses a wide spectrum of computational approaches oriented to prioritize which compounds from chemical libraries or repositories will be subjected to experimental in vitro and in vivo testing. VS can be broadly classifi ed into structure- and ligand-based approaches. Which VS methodology is preferable is highly dependent on the targeted system and the availability of experimental data and also on background considerations such as existing technical and economic resources. To the moment, VS has been underexplored for the discovery of new antiepileptic agents. In this chapter we discuss details on the general ligand-based procedures to undertake VS campaigns, with emphasis on some particular considerations for the case of antiepileptic drug development.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Springer  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
IN SILICO SCREENING  
dc.subject
EPILEPSY  
dc.subject
LIGAND-BASED APPROXIMATIONS  
dc.subject
VIRTUAL SCREENING  
dc.subject.classification
Otras Ciencias Químicas  
dc.subject.classification
Ciencias Químicas  
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS  
dc.title
Virtual Screening Applications in the Search of Novel Antiepileptic Drug Candidates  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.type
info:eu-repo/semantics/bookPart  
dc.type
info:ar-repo/semantics/parte de libro  
dc.date.updated
2020-06-05T15:49:05Z  
dc.journal.pagination
237-258  
dc.journal.pais
Alemania  
dc.journal.ciudad
Berlín  
dc.description.fil
Fil: Talevi, Alan. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencas Exactas. Laboratorio de Investigación y Desarrollo de Bioactivos; Argentina  
dc.description.fil
Fil: Bruno Blanch, Luis Enrique. Universidad Nacional de La Plata. Facultad de Ciencas Exactas. Laboratorio de Investigación y Desarrollo de Bioactivos; Argentina  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://link.springer.com/protocol/10.1007/978-1-4939-6355-3_13  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1007/978-1-4939-6355-3_13  
dc.conicet.paginas
387  
dc.source.titulo
Antiepileptic Drug Discovery. Novel Approaches